Advertisement

Topics

Latest "Biofield Corporation" News Stories

12:00 EST 11th December 2018 | BioPortfolio

Here are the most relevant search results for "Biofield Corporation" found in our extensive news archives from over 250 global news sources.

More Information about Biofield Corporation on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Biofield Corporation for you to read. Along with our medical data and news we also list Biofield Corporation Clinical Trials, which are updated daily. BioPortfolio also has a large database of Biofield Corporation Companies for you to search.

Showing "Biofield Corporation" News Articles 1–25 of 653

Relevant

Trivedi Global, Inc. and Karen Allen Announce Research Results of a Biofield Energy Treated Nutraceutical to Mitigate Inflammation and Autoimmune Disorders

HENDERSON, Nev. (PRWEB) August 23, 2018 Karen Allen, an evidence-based energy healer, today announces the impact of a biofield energy treated nutraceutical to increase immunity and improve anti-inflammatory, and immune function responses. Biomarkers for systemic and organ-specific inflamma...


Trivedi Global, Inc. with Julia McCammon Announces Research Results of a Biofield Energy Treated Nutraceutical to Mitigate Inflammation and Autoimmune Disorders

KITCHENER, Ontario (PRWEB) August 23, 2018 Julia Grace McCammon, an evidence-based energy healer, today announces the impact of a biofield energy treated nutraceutical to increase immunity and improve anti-inflammatory, and immune function responses. Biomarkers for systemic and organ-speci...

Trivedi Global, Inc. and Dr. William Plikerd Announce Research on the Impact of a Biofield Energy Treated Nutraceutical on Anti-Aging and Overall Skin Health

COLUMBUS, Ohio (PRWEB) August 22, 2018 Dr. William Plikerd, an evidence-based energy healer, announces today scientific research results on the significant impact of a biofield energy treated nutraceutical to improve skin health parameters including anti-wrinkling, skin hydration, elasticity,...


Trivedi Global, Inc. and Sally Henderson Announces Research Results on a Biofield Energy Treated Nutraceutical for Reducing Inflammation and Autoimmune Disorders

IOWA CITY, Iowa (PRWEB) August 28, 2018 Sally Jean Henderson, a scientifically validated holistic energy healer, today announces research results of the impact of a proprietary biofield energy treated nutraceutical supplement used in combating inflammation and autoimmune disorders. The pr...

Orion Corporation: Managers' transactions - EVK-Capital Oy

ORION CORPORATION      MANAGERS' TRANSACTIONS 31 MAY 2018 at 18.30 EEST              Orion Corporation: Managers' transactions - EVK-Capital Oy Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their c...

NES Health: Tooth Fairy Marketing

NES Health claims to scan the human biofield, detect imbalances, and correct them with infoceuticals. It's not science, it's clever marketing based on fantasy.

Ambu A/S: Articles of Association November 2018

  Attached the updated Articles of Association November 2018 Complete Articles of Association November 2018This announcement is distributed by West Corporation on behalf of West Corporation clients.The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.Source: Ambu A/S via Globenewswire

Orion Corporation: Managers' transactions - Anne Karvonen

ORION CORPORATION      MANAGERS' TRANSACTIONS 20 June 2018 at 11.45 EEST Orion Corporation: Managers' transactions - Anne Karvonen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons. ...

Orion Corporation: Managers' transactions - Nina Karvonen

ORION CORPORATION         MANAGERS' TRANSACTIONS 20 June 2018 at 12.00 EEST Orion Corporation: Managers' transactions - Nina Karvonen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated...

Mandatory notification of trade

Valborg Godal Vold, COO of Vistin Pharma ASA, and a primary insider, has on 18 September 2018 sold 50,000 shares in Vistin Pharma ASA at an average price of NOK 10.58 per share. Following this sale Valborg Godal Vold holds 50,000 shares in Vistin Pharma ASA. This announcement is distributed by West Corporation on behalf of West Corporation clients.The issuer of this announcement warrants that...

International Endeavors Corporation Hires Marketing Director

TEMECULA, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--International Endeavors Corporation (OTC:IDVV) announces the hiring of William Vinson as Marketing Director to expand sales of the Off Grid Grow Lab (“OGGL”). Mr. Vinson has over 35-years experience in managing the marketing efforts for innovative technology in emerging markets. He began sales efforts in the technology s...

Arrayit Corporation and TeleChem International Inc Celebrate 25 Years in Business

Sunnyvale, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces that management and staff are commemorating its 25-year business anniversary. On November 1, 1993, with two telephones and seed capital borrowed from their parents, entrepreneurs Rene Schena and Todd Martinsky founded industrial and specialty chemicals manu...

International Stem Cell Corporation Developed 3D Liver Structures

CARLSBAD, Calif., Aug. 06, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, announced today that ISCO’s Research and Development team has developed novel methods that efficiently generate...

Arrayit Corporation Announces Allergy Testing Agreement with Sutter Health

Sunnyvale, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces an allergy testing agreement with Northern California healthcare leader Sutter Health. The company is providing its proprietary microarray-based finger stick allergy testing services to Sutter Health via doctors in the Sutter Health-affiliated Palo Alto Med...

Vericel Corporation Prices $65 Million Public Offering of Common Stock

CAMBRIDGE, Mass., May 31, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced the pricing of its previously announced underwritten public offering of 5,000,000 shares of its common stock, at a price to the public of $13.00 per share.  The gross proceeds to Vericel from this offerin...

International Stem Cell Corporation to Launch Advanced Joint Supplement

CARLSBAD, Calif., June 05, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, announced today that the Company plans to launch its advanced joint supplement, designed to potentially reduce jo...

ContraFect Corporation Announces Proposed Public Offering of Common Stock

YONKERS, N.Y., July 26, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug-resistant infectious diseases, today announced that it has commenced an underwritten public offering of its common stock. All shares in the offering are to be sold by ContraFect. Th...

ContraFect Corporation Prices $10 Million Public Offering of Common Stock

YONKERS, N.Y., July 27, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug-resistant infectious diseases, today announced the pricing of its underwritten public offering of 5,000,000 shares of its common stock at a public offering price of $2.00 per share....

Marrone Bio Innovations Announces Distribution Partnership with Hop Tri Investment Corporation in Vietnam

Regalia®, Grandevo® and Majestene® to Offer Vietnamese Growers Effective Biological Solutions as Regional Chemical Pesticide Reduction Begins DAVIS, Calif., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, to...

Probably Relevant

Novan Extends Technical Production Capacity and Reaches Agreement with Orion Corporation

External manufacturing agreement reached to enable production of clinical trial materials for SB204 and the acne indication, with the potential to include additional product candidatesExtension of capacity complements existing internal operations, proprietary technological knowledge, intellectual property strategy and production skillsAgreement aligns with and supports global business development...

Arrayit Corporation Achieves Testing Accuracy Required for Medicare and Medicaid Reimbursement

Sunnyvale, CA , May 30, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces that the company has achieved the clinical testing accuracy required for reimbursement under Medicare and Medicaid.  Accuracy testing, supervised by the College of American Pathologists (CAP), assesses quantitative measurements of the immunoglobulin E (...

Arrayit Corporation Announces Nationwide Allergy Testing Sales and Distribution Network

Sunnyvale, June 18, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation Announces Nationwide Allergy Testing Sales and Distribution Network June 18, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces that the company has engaged a nationwide network of professional sales representatives (“sales reps”) to sell and distribute t...

International Stem Cell Corporation Expands Manufacturing Capabilities for Biomedical Products

CARLSBAD, Calif., July 10, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, announced today that its wholly owned subsidiary, Lifeline Cell Technology (LCT), has expanded its business and manufacturing capabilities to ful...

Arrayit Corporation Receives Approval for In-Store Promotions by a Major Retail Chain

Sunnyvale, Aug. 13, 2018 (GLOBE NEWSWIRE) -- August 13, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, has been approved for in-store allergy testing promotions by a major United States retailer.  Arrayit sales and marketing experts will conduct allergy test promotions in-store, and medical professionals at in-store clinics will col...

Arrayit Corporation Announces Brands Expansion of Proprietary Finger Stick Allergy Testing

Sunnyvale, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces expansion of its proprietary finger stick microarray allergy testing platform to a growing number of major market brands. Highly automated Arrayit technology is inherently suited to leveraging multiple brands and their unique venues and relationships to rea...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks